Dr Reddys Laboratories (RDY) Total Debt (2012 - 2026)

Dr Reddys Laboratories' Total Debt history runs 14 years deep, the most recent figure standing at $199.2 million for Q1 2026.

• In Q1 2026, Total Debt fell 62.43% year-over-year to $199.2 million; the TTM figure through Mar 2026 stood at $199.2 million (down 62.43% YoY), while the FY2026 annual figure was $194.0 million, up 90.2% from the prior year.
• Total Debt was $199.2 million for Q1 2026 at Dr Reddys Laboratories, up from $133.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $530.2 million in Q1 2025 to a low of $22.5 million in Q3 2022.
• Historically, Total Debt has averaged $171.0 million across 5 years, with a median of $111.7 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Total Debt sank 94.34% in 2022, then jumped 1118.34% in 2023.
• A 5-year view of Total Debt shows it stood at $22.5 million in 2022, then surged by 1118.34% to $274.3 million in 2023, then plunged by 67.96% to $87.9 million in 2024, then soared by 51.8% to $133.4 million in 2025, then jumped by 49.28% to $199.2 million in 2026.
• The last three Total Debt figures came in at $199.2 million (Q1 2026), $133.4 million (Q3 2025), and $530.2 million (Q1 2025), per Business Quant data.